alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Anterior Choroidal Artery Infarction in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kiessling, M; Kollmar, R; Schäbitz, WR; Schwab, S; Sommer, C | 1 |
| Diederich, K; Hanumanthiah, KM; Müller, HD; Schäbitz, WR; Schwab, S; Sommer, C | 1 |
| Barnes, KA; Buchan, AM; Huang, ZG; Lesiuk, H; Li, H; Smith, KE; Xue, D | 1 |
| Siesjö, B | 1 |
| Barnes, K; Buchan, AM; Huang, ZG; Lesiuk, HJ; Smith, KE; Xue, D | 1 |
| Cole, DJ; Drummond, JC; Kelly, PJ; Kimbro, JR; Patel, PM | 1 |
6 other study(ies) available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Exogenous brain-derived neurotrophic factor prevents postischemic downregulation of [3H]muscimol binding to GABA(A) receptors in the cortical penumbra.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Binding, Competitive; Brain Ischemia; Brain-Derived Neurotrophic Factor; Cerebral Cortex; Cerebral Infarction; Dizocilpine Maleate; Down-Regulation; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; GABA Agonists; Male; Muscimol; Neurons; Neuroprotective Agents; Rats; Rats, Wistar; Receptors, GABA-A; Receptors, N-Methyl-D-Aspartate; Tritium | 2003 |
Brain-derived neurotrophic factor but not forced arm use improves long-term outcome after photothrombotic stroke and transiently upregulates binding densities of excitatory glutamate receptors in the rat brain.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Autoradiography; Brain; Brain-Derived Neurotrophic Factor; Cerebral Infarction; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Forelimb; GABA Agonists; Intracranial Thrombosis; Ligands; Male; Motor Activity; Muscimol; Physical Therapy Modalities; Rats; Rats, Wistar; Receptors, Glutamate; Restraint, Physical; Stroke; Up-Regulation | 2008 |
AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anti-Anxiety Agents; Benzodiazepines; Cerebral Infarction; Cerebrovascular Disorders; Dizocilpine Maleate; Drug Administration Schedule; Injections, Intraperitoneal; Male; N-Methylaspartate; Quinoxalines; Rats; Rats, Wistar; Reperfusion | 1993 |
[Future treatment of stroke. Brain injury can be reduced with drugs].
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Calcium Channel Blockers; Cell Death; Cerebral Infarction; Humans; Microcirculation; N-Methylaspartate; Neuroglia; Time Factors | 1993 |
Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anti-Anxiety Agents; Benzodiazepines; Cerebral Cortex; Cerebral Infarction; Cerebrovascular Circulation; Injections, Intraperitoneal; Injections, Intravenous; Kidney; Male; N-Methylaspartate; Pilot Projects; Quinoxalines; Rats; Rats, Inbred SHR; Sodium Chloride | 1994 |
Isoflurane and pentobarbital reduce AMPA toxicity in vivo in the rat cerebral cortex.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Anesthetics, Inhalation; Animals; Blood Pressure; Cerebral Cortex; Cerebral Infarction; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; GABA Modulators; Heart Rate; Image Processing, Computer-Assisted; Isoflurane; Necrosis; Pentobarbital; Quinoxalines; Rats; Rats, Inbred WKY; Receptors, AMPA | 2000 |